Anemia in chronic kidney disease (CKD) causes the body to produce too few red blood cells. People with advanced kidney disease tend to develop this condition, and it can increase the risk of negative ...

daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

A cross-sectional study found that severe anemia was common in patients with chronic kidney disease (CKD) and was associated with lower glomerular filtration rate (eGFR) and multiple adverse outcomes.

ORLANDO, Fla.—Mitochondrial DNA copy number (mtDNA) and plasma levels of hepcidin hold promise as novel markers of anemia in CKD patients, data suggest. Madhumathi Rao, MD, Assistant Professor of ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease (CKD). Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

A new study used German data to assess the effects of CKD, anemia, or both on the development and eventual progression of HF among at-risk and symptomatic patients. The prevalence and severity of CKD ...

SGLT2 inhibitors may be a useful adjunct therapy to reduce anemia risk in patients with type 2 diabetes and early CKD. Anemia risk is lower among patients receiving SGLT2 inhibitors (SGLT2i) compared ...